Matarin Capital Management, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
Matarin Capital Management, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$3,261,000
-17.1%
129,607
-31.4%
0.80%
-3.4%
Q3 2020$3,936,000
-23.5%
188,878
-12.9%
0.82%
-19.7%
Q2 2020$5,148,000
-26.2%
216,743
-44.1%
1.03%
-5.2%
Q1 2020$6,980,000
-28.2%
387,985
-5.3%
1.08%
+16.6%
Q4 2019$9,723,000
-16.4%
409,908
-3.1%
0.93%
+5.7%
Q3 2019$11,630,000
+197.4%
423,230
+258.2%
0.88%
+213.9%
Q2 2019$3,910,000118,1480.28%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders